Evidence map›Paper›PMID 38940173›Full record

ArticleBioinformatics (Oxford, England)2024

CODEX: COunterfactual Deep learning for the in silico EXploration of cancer cell line perturbations.

Stefan Schrod, Helena U Zacharias, Tim Beißbarth, Anne-Christin Hauschild, Michael Altenbuchinger

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Stefan SchrodDepartment of Medical Bioinformatics, University Medical Center Göttingen, 37077 Niedersachsen, Germany.
Helena U ZachariasPeter L. Reichertz Institute for Medical Informatics of TU Braunschweig and Hannover Medical School, Hannover Medical School, 30625 Hannover, Germany.
Tim BeißbarthDepartment of Medical Bioinformatics, University Medical Center Göttingen, 37077 Niedersachsen, Germany.
Anne-Christin HauschildDepartment of Medical Informatics, University Medical Center Göttingen, 37075 Niedersachsen, Germany.
Michael AltenbuchingerDepartment of Medical Bioinformatics, University Medical Center Göttingen, 37077 Niedersachsen, Germany.

Funding

BMBFBMBF 01KD2101CBMBF 01KD2209DDeutsche ForschungsgemeinschaftDFG TRR274 408885537Digital Tissue Deconvolution-Aus Einzelzelldaten lernenFAIrPaCT 01KD2208AGerman Federal Ministry of Education and Research 01ZX1912AGerman Research Foundation AL 2355/1-1MATCH 01KU1910A
6 · The paper itself

Abstract

motivationHigh-throughput screens (HTS) provide a powerful tool to decipher the causal effects of chemical and genetic perturbations on cancer cell lines. Their ability to evaluate a wide spectrum of interventions, from single drugs to intricate drug combinations and CRISPR-interference, has established them as an invaluable resource for the development of novel therapeutic approaches. Nevertheless, the combinatorial complexity of potential interventions makes a comprehensive exploration intractable. Hence, prioritizing interventions for further experimental investigation becomes of utmost importance.

resultsWe propose CODEX (COunterfactual Deep learning for the in silico EXploration of cancer cell line perturbations) as a general framework for the causal modeling of HTS data, linking perturbations to their downstream consequences. CODEX relies on a stringent causal modeling strategy based on counterfactual reasoning. As such, CODEX predicts drug-specific cellular responses, comprising cell survival and molecular alterations, and facilitates the in silico exploration of drug combinations. This is achieved for both bulk and single-cell HTS. We further show that CODEX provides a rationale to explore complex genetic modifications from CRISPR-interference in silico in single cells. AVAILABILITY AND IMPLEMENTATION: Our implementation of CODEX is publicly available at https://github.com/sschrod/CODEX. All data used in this article are publicly available.

Indexed as

Computer SimulationDeep LearningAntineoplastic AgentsCell Line, TumorComputational BiologyHigh-Throughput Screening AssaysHumansNeoplasmsSoftwareAntineoplastic Agents

Identifiers

PMID38940173
PMCPMC11211812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.